• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Cyberonics

Anonymous board for Cyberonics
Replies
51
Views
48K
anonymous
Replies
0
Views
2K
anonymous
Replies
9
Views
13K
anonymous
Replies
0
Views
2K
anonymous
Replies
0
Views
3K
anonymous
Replies
0
Views
3K
anonymous
Replies
13
Views
7K
anonymous
Replies
0
Views
3K
anonymous
Replies
1
Views
3K
anonymous
Replies
4
Views
5K
anonymous
Replies
17
Views
8K
anonymous
Replies
2
Views
3K
anonymous
Replies
13
Views
16K
Anonymous
Replies
9
Views
16K
Anonymous
Replies
0
Views
4K
Anonymous
Replies
3
Views
8K
Anonymous
Replies
1
Views
6K
Anonymous
Replies
1
Views
6K
Anonymous